A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Knocking out two Byrds with one stone
It’s just days before the Senate is supposed to leave town for summer break, and they’re still engaged in a last-minute scramble to streamline their ambitious plan to lower drug prices. My colleague Rachel Cohrs has the details on what’s already changed — and what’s still changing.
